We are live on ! Find out more
BFM

Boothbay Fund Management Portfolio holdings

AUM $7.71B
1-Year Est. Return 106.31%
This Fund
S&P 500
This Quarter Est. Return
+14.31%
1 Year Est. Return
+106.31%
3 Year Est. Return
+266.76%
5 Year Est. Return
+310.53%
10 Year Est. Return
+1,580.35%
AUM
$4.05B
AUM Growth
-$342M
Cap. Flow
-$333M
Cap. Flow %
-8.21%
Top 10 Hldgs %
11.89%
Holding
2,058
New
529
Increased
346
Reduced
400
Closed
620

Sector Composition

Rank Sector Weight
1 Technology 14.25%
2 Healthcare 11.64%
3 Consumer Discretionary 10.2%
4 Industrials 7.56%
5 Financials 7.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATXI
1301
DELISTED
Avenue Therapeutics, Inc. Common Stock
ATXI
$82.2K ﹤0.01%
+41,089
New +$83.4K
CUTR
1302
DELISTED
Cutera, Inc.
CUTR
$81.1K ﹤0.01%
229,737
-97,033
-30% -$48.3K
ONFOW icon
1303
Onfolio Holdings Warrant
ONFOW
$50.1K
$80.4K ﹤0.01%
60,000
GBBKR
1304
DELISTED
Global Blockchain Acquisition Corp. Right
GBBKR
$80.4K ﹤0.01%
760,232
-107
-0% -$9
QETAR icon
1305
Quetta Acquisition Corp Right
QETAR
$77.7K ﹤0.01%
52,348
YOTAR
1306
DELISTED
Yotta Acquisition Corporation Right
YOTAR
$77.7K ﹤0.01%
925,000
MOBBW
1307
Mobilicom Ltd Warrants
MOBBW
$2.4B
$77.3K ﹤0.01%
20,300
TBMCR
1308
DELISTED
Trailblazer Merger Corporation I Rights
TBMCR
$77K ﹤0.01%
336,600
MGNX icon
1309
MacroGenics
MGNX
$248M
$76.4K ﹤0.01%
23,512
-8
-0% -$29
SHIP icon
1310
Seanergy Maritime Holdings
SHIP
$374M
$75.6K ﹤0.01%
+10,879
New +$97.7K
CPTNW
1311
DELISTED
Cepton, Inc. Warrant
CPTNW
$73.6K ﹤0.01%
22,591
VYGR icon
1312
Voyager Therapeutics
VYGR
$189M
$73.3K ﹤0.01%
12,926
+691
+6% +$4.46K
MIST icon
1313
Milestone Pharmaceuticals
MIST
$146M
$72.7K ﹤0.01%
30,790
+11
+0% +$19
PSNL icon
1314
Personalis
PSNL
$1.44B
$72.6K ﹤0.01%
+12,560
New +$58K
SPCE icon
1315
Virgin Galactic
SPCE
$379M
$71.8K ﹤0.01%
12,208
+1,932
+19% +$12.9K
BRACR
1316
DELISTED
Broad Capital Acquisition Corp Rights
BRACR
$71.5K ﹤0.01%
650,000
UIS icon
1317
Unisys
UIS
$218M
$67.7K ﹤0.01%
+10,695
New +$74.6K
VTGN icon
1318
VistaGen Therapeutics
VTGN
$12.3M
$66.1K ﹤0.01%
+22,415
New +$63.1K
MARXR
1319
DELISTED
Mars Acquisition Corp. Rights
MARXR
$64K ﹤0.01%
168,396
KLTR icon
1320
Kaltura
KLTR
$211M
$63.3K ﹤0.01%
28,773
-20,422
-42% -$37.3K
DBI icon
1321
Designer Brands
DBI
$336M
$62.9K ﹤0.01%
+11,788
New +$66K
RFACR
1322
DELISTED
RF Acquisition Corp. Rights
RFACR
$62.5K ﹤0.01%
400,000
NEXRW
1323
Nexera Technologies Ltd Warrant
NEXRW
$33.1K
$61.8K ﹤0.01%
24,038
KPTI icon
1324
Karyopharm Therapeutics
KPTI
$44.4M
$61.3K ﹤0.01%
6,042
-31
-0.5% -$375
SVREW
1325
SaverOne 2014 Ltd Warrant
SVREW
$60.5K ﹤0.01%
60,500

Similar funds

Boothbay Fund Management's Q4 2024 Portfolio in Review

As of Q4 2024, Boothbay Fund Management held 2,058 positions worth $4.05B, down 7.8% from $4.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Boothbay Fund Management withdrew a net $333M in Q4 2024, closing 620 positions and reducing 400 holdings. Its most notable exit was Nova Vision Acquisition Corp. Warrant, an estimated $18.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Boothbay Fund Management opened a new position in Cardinal Health worth $10.8M.

  • Boothbay Fund Management's largest Q4 2024 buy was Cardinal Health: 91,430 shares worth $10.8M.
  • Boothbay Fund Management added most to Arthur J. Gallagher & Co in Q4 2024, an estimated $20M increase.
  • Boothbay Fund Management's biggest Q4 2024 reduction was Dell, cutting an estimated $36.8M.
  • Boothbay Fund Management fully exited Nova Vision Acquisition Corp. Warrant in Q4 2024, selling an estimated $18.1M.
  • Boothbay Fund Management's ten largest holdings make up 12% of its $4.05B portfolio in Q4 2024.
  • Boothbay Fund Management opened 529 new positions and closed 620 in Q4 2024.
  • Boothbay Fund Management's portfolio value fell 7.8% quarter-over-quarter to $4.05B.

Based on Boothbay Fund Management's 13F filing for Q4 2024, filed 14 Feb 2025.